Business Description
Genix Pharmaceuticals Corp
NAICS : 325412
SIC : 3741
ISIN : CA0209261019
Description
Financial Strength
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.01 | |||||
Equity-to-Asset | -5.86 | |||||
Debt-to-Equity | -0.54 | |||||
Debt-to-EBITDA | -0.2 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | -135.57 | |||||
Beneish M-Score | -16.73 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | -109.1 | |||||
3-Year EPS without NRI Growth Rate | 15.7 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 44.35 | |||||
9-Day RSI | 34.48 | |||||
14-Day RSI | 30.12 | |||||
6-1 Month Momentum % | -7.69 | |||||
12-1 Month Momentum % | 50 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.14 | |||||
Quick Ratio | 0.04 | |||||
Cash Ratio | 0.01 | |||||
Days Inventory | 58546 | |||||
Days Sales Outstanding | 474.5 | |||||
Days Payable | 97820 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Shareholder Yield % | -13.96 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 75 | |||||
Operating Margin % | -10325 | |||||
Net Margin % | -99925 | |||||
FCF Margin % | -5200 | |||||
ROA % | -417.05 | |||||
ROIC % | -21.94 | |||||
Years of Profitability over Past 10-Year | 2 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
EV-to-EBIT | -0.72 | |||||
EV-to-EBITDA | -0.75 | |||||
EV-to-Revenue | 700.5 | |||||
EV-to-FCF | -13.47 | |||||
Earnings Yield (Greenblatt) % | -138.89 | |||||
FCF Yield % | -10.03 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Genix Pharmaceuticals Corp Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil C$) | 0.004 | ||
EPS (TTM) (C$) | -0.063 | ||
Beta | 0.53 | ||
Volatility % | 157.21 | ||
14-Day RSI | 30.12 | ||
14-Day ATR (C$) | 0.001342 | ||
20-Day SMA (C$) | 0.03725 | ||
12-1 Month Momentum % | 50 | ||
52-Week Range (C$) | 0.015 - 0.09 | ||
Shares Outstanding (Mil) | 59.22 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 4 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Genix Pharmaceuticals Corp Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Genix Pharmaceuticals Corp Stock Events
Event | Date | Price(C$) | ||
---|---|---|---|---|
No Event Data |
Genix Pharmaceuticals Corp Frequently Asked Questions
What is Genix Pharmaceuticals Corp(TSXV:GENX)'s stock price today?
When is next earnings date of Genix Pharmaceuticals Corp(TSXV:GENX)?
Does Genix Pharmaceuticals Corp(TSXV:GENX) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |